首页> 外文期刊>Critical care medicine >Reversal of acute coagulopathy during hypotensive resuscitation using small-volume 7.5% NaCl adenocaine and Mg2+ in the rat model of severe hemorrhagic shock
【24h】

Reversal of acute coagulopathy during hypotensive resuscitation using small-volume 7.5% NaCl adenocaine and Mg2+ in the rat model of severe hemorrhagic shock

机译:小剂量7.5%NaCl腺苷和Mg2 +在严重失血性休克大鼠模型降压复苏过程中急性凝血病的逆转

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: Acute traumatic coagulopathy occurs early in hemorrhagic trauma and is a major contributor to mortality and morbidity. Our aim was to examine the effect of small-volume 7.5% NaCl adenocaine (adenosine and lidocaine, adenocaine) and Mg on hypotensive resuscitation and coagulopathy in the rat model of severe hemorrhagic shock. DESIGN: Prospective randomized laboratory investigation. SUBJECTS: A total of 68 male Sprague Dawley Rats. INTERVENTION: Post-hemorrhagic shock treatment for acute traumatic coagulopathy. MEASUREMENTS AND METHODS: Nonheparinized male Sprague-Dawley rats (300-450 g, n = 68) were randomly assigned to either: 1) untreated; 2) 7.5% NaCl; 3) 7.5% NaCl adenocaine; 4) 7.5% NaCl Mg; or 5) 7.5% NaCl adenocaine/Mg. Hemorrhagic shock was induced by phlebotomy to mean arterial pressure of 35-40 mm Hg for 20 mins (~40% blood loss), and animals were left in shock for 60 mins. Bolus (0.3 mL) was injected into the femoral vein and hemodynamics monitored. Blood was collected in Na citrate (3.2%) tubes, centrifuged, and the plasma snap frozen in liquid N2 and stored at -80°C. Coagulation was assessed using activated partial thromboplastin times and prothrombin times. RESULTS: Small-volume 7.5% NaCl adenocaine and 7.5% NaCl adenocaine/Mg were the only two groups that gradually increased mean arterial pressure 1.6-fold from 38-39 mm Hg to 52 and 64 mm Hg, respectively, at 60 mins (p < .05). Baseline plasma activated partial thromboplastin time was 17 ± 0.5 secs and increased to 63 ± 21 secs after bleeding time, and 217 ± 32 secs after 60-min shock. At 60-min resuscitation, activated partial thromboplastin time values for untreated, 7.5% NaCl, 7.5% NaCl/Mg, and 7.5% NaCl adenocaine rats were 269 ± 31 secs, 262 ± 38 secs, 150 ± 43 secs, and 244 ± 38 secs, respectively. In contrast, activated partial thromboplastin time for 7.5% NaCl adenocaine/Mg was 24 ± 2 secs (p < .05). Baseline prothrombin time was 28 ± 0.8 secs (n = 8) and followed a similar pattern of correction. CONCLUSIONS: Plasma activated partial thromboplastin time and prothrombin time increased over 10-fold during the bleed and shock periods prior to resuscitation, and a small-volume (~1 mL/kg) IV bolus of 7.5% NaCl AL/Mg was the only treatment group that raised mean arterial pressure into the permissive range and returned activated partial thromboplastin time and prothrombin time clotting times to baseline at 60 mins.
机译:目的:急性创伤性凝血病发生在出血性创伤的早期,是导致死亡率和发病率的主要因素。我们的目的是检验小剂量7.5%NaCl腺苷(腺苷和利多卡因,腺苷)和Mg在重度失血性休克大鼠模型中对降压复苏和凝血功能的影响。设计:前瞻性随机实验室调查。受试者:总共68只雄性Sprague Dawley大鼠。干预:出血后休克治疗急性创伤性凝血病。测量和方法:将未肝素化的雄性Sprague-Dawley大鼠(300-450 g,n = 68)随机分配至: 2)7.5%NaCl; 3)7.5%NaCl腺苷; 4)7.5%NaCl镁;或5)7.5%NaCl腺苷/ Mg。静脉切开术引起出血性休克,平均动脉压为35-40 mm Hg,持续20分钟(失血量约40%),动物休克60分钟。将大丸(0.3 mL)注入股静脉并监测血流动力学。将血液收集在柠檬酸钠(3.2%)试管中,进行离心,并将血浆速冻在液体N2中,并保存在-80°C下。使用活化的部分凝血活酶时间和凝血酶原时间评估凝血。结果:小剂量7.5%NaCl腺苷和7.5%NaCl腺苷/ Mg是仅有的两组在60分钟时逐渐将平均动脉压从38-39 mm Hg分别增加至52和64 mm Hg 1.6倍(p <.05)。基线血浆激活的部分凝血活酶时间为17±0.5秒,出血后增加至63±21秒,电击60分钟后增加为217±32秒。复苏60分钟时,未经治疗的7.5%NaCl,7.5%NaCl / Mg和7.5%NaCl腺苷大鼠的活化部分凝血活酶时间值是269±31秒,262±38秒,150±43秒和244±38秒秒。相反,7.5%NaCl腺苷/ Mg的活化部分凝血活酶时间为24±2秒(p <.05)。基线凝血酶原时间为28±0.8秒(n = 8),并遵循类似的校正模式。结论:在复苏前的出血和休克期间,血浆激活的部分凝血活酶时间和凝血酶原时间增加了10倍以上,小剂量(〜1 mL / kg)静脉推注7.5%NaCl AL / Mg是唯一的治疗方法该组将平均动脉压提高到允许范围,并使活化的部分凝血活酶时间和凝血酶原时间的凝血时间在60分钟时恢复到基线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号